A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis

Clinical trial NCT00233571 · COMPLETED

Trial details

NCT number: NCT00233571
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2000-06-01
Primary completion: 2006-06-01
Enrollment: 796

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.